Tag: OTCQB:RLLVF

September 23, 2019

Relevium CEO: We’re Positioned to Lead Latin America’s Cannabis Industry

Relevium CEO Aurelio Useche joined the Investing News Network to provide an overview of the company and an update on...
August 1, 2019

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that the company hit a record high...
July 10, 2019

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients
June 27, 2019

Leveraging Cannabinoids in Pediatric Medicine

Research-based evidence has shown potential for health improvements from the use of medical cannabinoids in pediatric medicine.
June 19, 2019

Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSXV:RLV,  OTCQB:RLLVF and Frankfurt:6BX (the “Company” or “Relevium”), is...
June 13, 2019

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a...
June 11, 2019

Relevium Closes Private Placement Financing

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it...